2022 Annual Meeting | C103

��ɫ��

2022 Annual Meeting | C103 - Sleep Apnea

Date Tuesday 04/05/22

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Yasemin Tashman, MD

Topic(s) Sleep

Learning Objectives Sleep apnea is highly prevalent in patients with neurological disorders and often underdiagnosed in this population. This course will begin with the classification, diagnosis and treatments for sleep disordered breathing. We will delve deeper into the literature showing obstructive sleep apnea as an independent risk factor for stroke and the importance of timely diagnosis and treatment as crucial primary and secondary stroke prevention tools. We will also discuss the nuances of sleep apnea in the aging population, focusing on evidence from basic science and clinical studies supporting a relationship between OSA and dementia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:35 PM PDT	Speaker	Updates in Sleep Apnea Yasemin Tashman, MD
01:00 PM - 01:00 PM PDT	Speaker	Walk-in Slides Yasemin Tashman, MD
01:35 PM - 02:10 PM PDT	Speaker	Stroke and Sleep Apnea Joyce K. Lee-Iannotti, MD, FAAN
02:10 PM - 02:45 PM PDT	Speaker	Dementia and Sleep Apnea Diego Z. Carvalho, MD
02:45 PM - 03:00 PM PDT	Q&A	Questions and Answers Joyce K. Lee-Iannotti, MD, FAAN, Yasemin Tashman, MD, Diego Z. Carvalho, MD

Faculty Disclosures
Joyce K. Lee-Iannotti, MD, FAAN	Dr. Lee-Iannotti has nothing to disclose.
Yasemin Tashman, MD	Dr. Tashman has nothing to disclose.
Diego Z. Carvalho, MD	The institution of Dr. Carvalho has received research support from NIA/NIH.

��ɫ����

��ɫ����

��ɫ��

��ɫ��